Is Reviva Pharmaceuticals Stock a Good Investment?
Reviva Pharmaceuticals Investment Advice | RVPHW |
- Examine Reviva Pharmaceuticals' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Reviva Pharmaceuticals' leadership team and their track record. Good management can help Reviva Pharmaceuticals navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Reviva Pharmaceuticals' business and its evolving consumer preferences.
- Compare Reviva Pharmaceuticals' performance and market position to its competitors. Analyze how Reviva Pharmaceuticals is positioned in terms of product offerings, innovation, and market share.
- Check if Reviva Pharmaceuticals pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Reviva Pharmaceuticals' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Reviva Pharmaceuticals Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Reviva Pharmaceuticals Holdings is a good investment.
Sell | Buy |
Buy
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Reviva Pharmaceuticals Stock
Researching Reviva Pharmaceuticals' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Reviva Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Reviva Pharmaceuticals' research are outlined below:
| Reviva Pharmaceuticals is way too risky over 90 days horizon | |
| Reviva Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Reviva Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Reviva Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Reviva Pharmaceuticals Holdings has accumulated 17.98 M in total debt. Reviva Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Reviva Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (39.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reviva Pharmaceuticals Holdings has accumulated about 353.26 K in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Reviva Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Reviva Pharmaceuticals Holdings, Inc. Given Average Rating of Buy by Analysts - MarketBeat |
Reviva Pharmaceuticals Quarterly Cost Of Revenue |
|
Reviva Pharmaceuticals' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.81 M.Market Cap |
|
Reviva Pharmaceuticals' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | -1.9 M | -1.8 M | |
| Return On Capital Employed | -7 M | -6.6 M | |
| Return On Assets | -1.9 M | -1.8 M | |
| Return On Equity | -7.9 M | -7.5 M |
Determining Reviva Pharmaceuticals' profitability involves analyzing its financial statements and using various financial metrics to determine if Reviva Pharmaceuticals is a good buy. For example, gross profit margin measures Reviva Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Reviva Pharmaceuticals' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Reviva Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Reviva Pharmaceuticals Holdings. Check Reviva Pharmaceuticals' Beneish M Score to see the likelihood of Reviva Pharmaceuticals' management manipulating its earnings.
Evaluate Reviva Pharmaceuticals' management efficiency
Reviva Pharmaceuticals has return on total asset (ROA) of (3.2778) % which means that it has lost $3.2778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.9506) %, meaning that it generated substantial loss on money invested by shareholders. Reviva Pharmaceuticals' management efficiency ratios could be used to measure how well Reviva Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to about (1.8 M) in 2025. Return On Capital Employed is likely to climb to about (6.6 M) in 2025. At this time, Reviva Pharmaceuticals' Other Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 504.5 K in 2025, whereas Total Assets are likely to drop slightly above 18.2 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.22 | 0.21 | |
| Tangible Book Value Per Share | 0.22 | 0.21 | |
| Price Book Value Ratio | 19.29 | 20.25 | |
| Price Fair Value | 19.29 | 20.25 | |
| Enterprise Value | 89.3 M | 93.7 M |
Examining the leadership quality of Reviva Pharmaceuticals Holdings offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Beta (0.12) |
Basic technical analysis of Reviva Stock
As of the 17th of February 2025, Reviva Pharmaceuticals holds the Coefficient Of Variation of 796.74, semi deviation of 15.44, and Risk Adjusted Performance of 0.0986. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Reviva Pharmaceuticals, as well as the relationship between them. Please check Reviva Pharmaceuticals standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Reviva Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 0.13 per share. As Reviva Pharmaceuticals appears to be a penny stock we also advise to check out its total risk alpha numbers.Reviva Pharmaceuticals' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Reviva Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Reviva Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Reviva Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Patel Purav over two months ago Discretionary transaction by Patel Purav of tradable shares of Reviva Pharmaceuticals subject to Rule 16b-3 | ||
Laxminarayan Bhat over six months ago Acquisition by Laxminarayan Bhat of 443000 shares of Reviva Pharmaceuticals at 6.74 subject to Rule 16b-3 | ||
Saxena Parag over six months ago Acquisition by Saxena Parag of 4000 shares of Reviva Pharmaceuticals at 4.73 subject to Rule 16b-3 |
Understand Reviva Pharmaceuticals' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Reviva Pharmaceuticals' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0986 | |||
| Market Risk Adjusted Performance | 2.68 | |||
| Mean Deviation | 15.74 | |||
| Semi Deviation | 15.44 | |||
| Downside Deviation | 18.66 | |||
| Coefficient Of Variation | 796.74 | |||
| Standard Deviation | 21.74 | |||
| Variance | 472.77 | |||
| Information Ratio | 0.125 | |||
| Jensen Alpha | 2.72 | |||
| Total Risk Alpha | 2.69 | |||
| Sortino Ratio | 0.1457 | |||
| Treynor Ratio | 2.67 | |||
| Maximum Drawdown | 135.71 | |||
| Value At Risk | (23.33) | |||
| Potential Upside | 29.41 | |||
| Downside Variance | 348.19 | |||
| Semi Variance | 238.26 | |||
| Expected Short fall | (22.71) | |||
| Skewness | 0.8424 | |||
| Kurtosis | 2.79 |
| Risk Adjusted Performance | 0.0986 | |||
| Market Risk Adjusted Performance | 2.68 | |||
| Mean Deviation | 15.74 | |||
| Semi Deviation | 15.44 | |||
| Downside Deviation | 18.66 | |||
| Coefficient Of Variation | 796.74 | |||
| Standard Deviation | 21.74 | |||
| Variance | 472.77 | |||
| Information Ratio | 0.125 | |||
| Jensen Alpha | 2.72 | |||
| Total Risk Alpha | 2.69 | |||
| Sortino Ratio | 0.1457 | |||
| Treynor Ratio | 2.67 | |||
| Maximum Drawdown | 135.71 | |||
| Value At Risk | (23.33) | |||
| Potential Upside | 29.41 | |||
| Downside Variance | 348.19 | |||
| Semi Variance | 238.26 | |||
| Expected Short fall | (22.71) | |||
| Skewness | 0.8424 | |||
| Kurtosis | 2.79 |
Consider Reviva Pharmaceuticals' intraday indicators
Reviva Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Reviva Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Reviva Pharmaceuticals time-series forecasting models is one of many Reviva Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Reviva Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Reviva Stock media impact
Far too much social signal, news, headlines, and media speculation about Reviva Pharmaceuticals that are available to investors today. That information is available publicly through Reviva media outlets and privately through word of mouth or via Reviva internal channels. However, regardless of the origin, that massive amount of Reviva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Reviva Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Reviva Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Reviva Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Reviva Pharmaceuticals alpha.
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.